Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GPCR |
---|---|---|
09:32 ET | 7596 | 51.51 |
09:34 ET | 920 | 51.525 |
09:36 ET | 400 | 51.7099 |
09:38 ET | 1221 | 51.65 |
09:39 ET | 743 | 51.395 |
09:41 ET | 10177 | 50.89 |
09:43 ET | 600 | 50.8 |
09:45 ET | 9164 | 50.6206 |
09:48 ET | 2100 | 50.72 |
09:50 ET | 2280 | 50.695 |
09:52 ET | 6693 | 50.935 |
09:54 ET | 200 | 50.95 |
09:56 ET | 3550 | 50.39 |
09:57 ET | 2159 | 50.3 |
09:59 ET | 4438 | 49.9 |
10:01 ET | 2423 | 49.6791 |
10:03 ET | 5781 | 49.6 |
10:06 ET | 16730 | 49.61 |
10:08 ET | 2515 | 49.837 |
10:10 ET | 7081 | 49.99 |
10:12 ET | 1000 | 49.795 |
10:14 ET | 3679 | 49.75 |
10:15 ET | 2324 | 49.94 |
10:17 ET | 1000 | 50 |
10:19 ET | 1865 | 50.065 |
10:21 ET | 8100 | 49.45 |
10:24 ET | 18462 | 49.0875 |
10:26 ET | 1905 | 49.175 |
10:28 ET | 3870 | 49.4 |
10:30 ET | 6938 | 49.27 |
10:32 ET | 2200 | 49.12 |
10:33 ET | 4470 | 49.105 |
10:35 ET | 31816 | 49.09 |
10:37 ET | 8695 | 49 |
10:39 ET | 350 | 48.9 |
10:42 ET | 5223 | 48.97 |
10:44 ET | 21886 | 48.99 |
10:46 ET | 4142 | 49.335 |
10:48 ET | 6693 | 49.48 |
10:50 ET | 1682 | 49.33 |
10:51 ET | 400 | 49.335 |
10:53 ET | 500 | 49.28 |
10:55 ET | 500 | 49.075 |
10:57 ET | 1018 | 49.055 |
11:00 ET | 3100 | 48.96 |
11:02 ET | 2580 | 49.075 |
11:04 ET | 10539 | 49.085 |
11:06 ET | 1900 | 49.08 |
11:08 ET | 600 | 49.08 |
11:09 ET | 5093 | 48.77 |
11:11 ET | 3420 | 48.79 |
11:13 ET | 23398 | 48.9 |
11:15 ET | 600 | 48.97 |
11:18 ET | 1500 | 49.25 |
11:20 ET | 2400 | 49.075 |
11:22 ET | 1100 | 49.3 |
11:24 ET | 600 | 49.2 |
11:26 ET | 900 | 49.23 |
11:27 ET | 1072 | 49.18 |
11:29 ET | 2950 | 49.31 |
11:31 ET | 700 | 49.43 |
11:33 ET | 100 | 49.37 |
11:36 ET | 1600 | 49.3989 |
11:38 ET | 800 | 49.41 |
11:40 ET | 1676 | 49.3375 |
11:42 ET | 1000 | 49.29 |
11:44 ET | 650 | 49.265 |
11:45 ET | 500 | 49.215 |
11:47 ET | 1084 | 49.125 |
11:49 ET | 1477 | 48.98 |
11:51 ET | 3500 | 48.97 |
11:54 ET | 700 | 48.98 |
11:56 ET | 3640 | 48.88 |
11:58 ET | 900 | 48.895 |
12:00 ET | 3100 | 48.85 |
12:02 ET | 914 | 48.8 |
12:03 ET | 4100 | 48.29 |
12:05 ET | 3392 | 48.31 |
12:07 ET | 2035 | 48.39 |
12:09 ET | 900 | 48.2836 |
12:12 ET | 2847 | 48.5 |
12:14 ET | 1942 | 48.57 |
12:16 ET | 1138 | 48.73 |
12:18 ET | 1400 | 48.47 |
12:20 ET | 931 | 48.51 |
12:21 ET | 2000 | 48.58 |
12:23 ET | 1100 | 48.76 |
12:25 ET | 690 | 48.77 |
12:27 ET | 1600 | 48.575 |
12:30 ET | 400 | 48.35 |
12:32 ET | 2087 | 48.39 |
12:34 ET | 3167 | 48.5 |
12:36 ET | 1336 | 48.4 |
12:38 ET | 2742 | 48.56 |
12:39 ET | 7838 | 48.6394 |
12:41 ET | 1481 | 48.62 |
12:43 ET | 2205 | 48.695 |
12:45 ET | 200 | 48.715 |
12:48 ET | 1910 | 48.7622 |
12:50 ET | 610 | 48.715 |
12:52 ET | 1089 | 48.79 |
12:54 ET | 2650 | 48.74 |
12:56 ET | 3166 | 48.39 |
12:57 ET | 600 | 48.395 |
12:59 ET | 3833 | 48.495 |
01:01 ET | 2087 | 48.385 |
01:03 ET | 3516 | 48.33 |
01:06 ET | 300 | 48.32 |
01:08 ET | 3000 | 48.195 |
01:10 ET | 4336 | 48.28 |
01:12 ET | 37034 | 47.745 |
01:14 ET | 1194 | 47.765 |
01:15 ET | 903 | 47.78 |
01:17 ET | 12510 | 47.7805 |
01:19 ET | 200 | 47.72 |
01:21 ET | 1074 | 47.6 |
01:24 ET | 4877 | 47.52 |
01:26 ET | 900 | 47.462 |
01:28 ET | 10112 | 47.215 |
01:30 ET | 20091 | 47.265 |
01:32 ET | 37997 | 46.8 |
01:33 ET | 10322 | 46.63 |
01:35 ET | 18899 | 47.37 |
01:37 ET | 8202 | 46.84 |
01:39 ET | 600 | 46.85 |
01:42 ET | 3790 | 46.905 |
01:44 ET | 1995 | 46.83 |
01:46 ET | 3288 | 46.87 |
01:48 ET | 4900 | 47.195 |
01:50 ET | 400 | 47.195 |
01:51 ET | 1200 | 47.345 |
01:53 ET | 18466 | 47.48 |
01:55 ET | 7799 | 47.365 |
01:57 ET | 5218 | 47.38 |
02:00 ET | 17385 | 47.35 |
02:02 ET | 10074 | 47.37 |
02:04 ET | 2736 | 47.46 |
02:06 ET | 2450 | 47.435 |
02:08 ET | 3426 | 47.42 |
02:09 ET | 700 | 47.445 |
02:11 ET | 3431 | 47.425 |
02:13 ET | 2316 | 47.285 |
02:15 ET | 596 | 47.3 |
02:18 ET | 24499 | 47.395 |
02:20 ET | 4750 | 47.285 |
02:22 ET | 500 | 47.33 |
02:24 ET | 7099 | 47.59 |
02:26 ET | 100 | 47.63 |
02:27 ET | 2016 | 47.66 |
02:29 ET | 901 | 47.75 |
02:31 ET | 2531 | 47.61 |
02:33 ET | 1293 | 47.59 |
02:36 ET | 900 | 47.47 |
02:38 ET | 3948 | 47.63 |
02:40 ET | 900 | 47.635 |
02:42 ET | 504 | 47.6011 |
02:44 ET | 2295 | 47.49 |
02:45 ET | 1328 | 47.56 |
02:47 ET | 3004 | 47.67 |
02:49 ET | 1781 | 47.69 |
02:51 ET | 1132 | 47.7 |
02:54 ET | 3332 | 47.55 |
02:56 ET | 3876 | 47.7 |
02:58 ET | 2489 | 47.77 |
03:00 ET | 1925 | 47.63 |
03:02 ET | 5081 | 47.96 |
03:03 ET | 9701 | 47.96 |
03:05 ET | 11800 | 48.06 |
03:07 ET | 5273 | 48.26 |
03:09 ET | 1809 | 48.25 |
03:12 ET | 4742 | 48.29 |
03:14 ET | 6778 | 48.31 |
03:16 ET | 16687 | 47.94 |
03:18 ET | 2801 | 47.86 |
03:20 ET | 901 | 47.92 |
03:21 ET | 1736 | 47.88 |
03:23 ET | 20361 | 48.33 |
03:25 ET | 12208 | 48.305 |
03:27 ET | 2707 | 48.33 |
03:30 ET | 4616 | 48.05 |
03:32 ET | 4439 | 47.91 |
03:34 ET | 2762 | 48.04 |
03:36 ET | 1619 | 48.09 |
03:38 ET | 5148 | 48.16 |
03:39 ET | 2465 | 48.0288 |
03:41 ET | 3625 | 47.87 |
03:43 ET | 2775 | 47.94 |
03:45 ET | 5055 | 47.89 |
03:48 ET | 3552 | 48.14 |
03:50 ET | 2594 | 47.955 |
03:52 ET | 8554 | 48.065 |
03:54 ET | 14170 | 48.345 |
03:56 ET | 13214 | 48.47 |
03:57 ET | 15789 | 48.105 |
03:59 ET | 27119 | 48.17 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Structure Therapeutics Inc | 2.7B | -20.8x | --- |
Xenon Pharmaceuticals Inc | 2.8B | -13.7x | --- |
MoonLake Immunotherapeutics | 2.6B | -55.2x | --- |
Geron Corp | 2.9B | -14.1x | --- |
SpringWorks Therapeutics Inc | 2.9B | -7.5x | --- |
Biohaven Ltd | 3.0B | -5.0x | --- |
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.32 |
Book Value | $9.76 |
P/E Ratio | -20.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.